Health ❯ Medical Treatments

Pharmacology

GLP-1 Receptor Agonists Weight Loss Medications Medications Antibiotics Ethics Corticosteroids RNA-targeted Therapies Endocrine Disorders Steroid Medications Antifungal Medications Sleep Disorders Antipsychotic Medications Anticoagulants Antihypertensive Medications Botulinum Toxin Drug Development Gene Therapy Levodopa Photopharmacology Antiplatelet Drugs Dopamine Treatments Diabetes Medications Complement Inhibitors Allergy Medications Bone Health Medications

Eplontersen Fails to Cut Cardiovascular Deaths or Recurrent Events in Large ATTR-CM Trial

High baseline use of transthyretin stabilizers likely masked any incremental benefit and left prespecified subgroup signals favoring unstabilized or early-stage patients.

Experts Flag Nutrition Risks With GLP-1 Weight-Loss Drugs

AI Motion Analysis Uncovers Earliest Parkinson’s Sign in Mice